Philippe Tramoy

Philippe Tramoy is on the Board of Directors at PEP-Therapy. Philippe is also the Investment Director of Quadrivium 1 seed fund at Seventure Partners. Former business development manager in Europe and Israel within the biotechnology market at Rhodia Corporate, Rhodia Chirex, and Rhodia Pharma Solutions. Founder and former Managing Partner of CBDMT, a Market & Business Intelligence company.